Literature DB >> 2001450

Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level.

G R Ryan1, S E Milton, A F Lopez, P G Bardy, M A Vadas, M F Shannon.   

Abstract

Interleukin-3 (IL-3) is a hematopoietic growth factor that regulates the differentiation of multilineage and committed progenitor cells and the functions of some mature blood cells. The expression of human IL-3 appears to be restricted to stimulated T lymphocytes. We have investigated the kinetics and mechanisms involved in the induction of IL-3 expression in the human T lymphocytic tumor cell line Jurkat. We show that accumulation of IL-3 mRNA is controlled at both the transcriptional and posttranscriptional level. Transcription of the IL-3 gene in these cells appears to be constitutive but no IL-3 mRNA was detected in unstimulated cells, indicating that in resting cells IL-3 mRNA is highly unstable. Treatment with phytohemagglutinin (PHA) induced a small and transient increase in the IL-3 gene transcription rate and led to the production of detectable levels of IL-3 mRNA and protein. Optimal induction of IL-3 expression required a second stimulus. Costimulation of Jurkat cells with both phorbol myristate acetate and PHA caused both a transient increase in IL-3 gene transcription, which is dependent on new protein synthesis, and also a transient increase in mRNA stability.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001450

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer.

Authors:  P N Cockerill; M F Shannon; A G Bert; G R Ryan; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

2.  A human interleukin 3 analog with increased biological and binding activities.

Authors:  A F Lopez; M F Shannon; S Barry; J A Phillips; B Cambareri; M Dottore; P Simmons; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter.

Authors:  W Zhang; J Zhang; M Kornuc; K Kwan; R Frank; S D Nimer
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

4.  The granulocyte-macrophage colony-stimulating factor promoter cis-acting element CLE0 mediates induction signals in T cells and is recognized by factors related to AP1 and NFAT.

Authors:  E S Masuda; H Tokumitsu; A Tsuboi; J Shlomai; P Hung; K Arai; N Arai
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

5.  Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins.

Authors:  Adele F Holloway; Sudha Rao; Xinxin Chen; M Frances Shannon
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

6.  The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells.

Authors:  José A González-Feliciano; Marimar Hernández-Pérez; Luis A Estrella; Daisy D Colón-López; Armando López; Marina Martínez; Kirla R Maurás-Rivera; Clarivel Lasalde; Daviana Martínez; Félix Araujo-Pérez; Carlos I González
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  Molecular regulation of the human IL-3 gene: inducible T cell-restricted expression requires intact AP-1 and Elf-1 nuclear protein binding sites.

Authors:  L R Gottschalk; D M Giannola; S G Emerson
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.